Kothari Hema, Kumar Pranav, Sundar Shyam, Singh Neeloo
Drug Target Discovery and Development Division, Central Drug Research Institute, Lucknow, India.
Parasitol Int. 2007 Mar;56(1):77-80. doi: 10.1016/j.parint.2006.10.005. Epub 2006 Dec 12.
Resistance to antimonials has become a clinical threat in the treatment of visceral leishmaniasis (VL). Unravelling the resistance mechanism needs attention to circumvent the problem of drug resistance. In one of the resistant isolates, we earlier identified a gene (PG1) implicated in antimony resistance whose localization in the present study was confirmed on the pellicular plasma membrane of the parasite thereby indicating towards membrane modification as a mechanism of resistance in this resistant isolate.
对锑剂的耐药性已成为内脏利什曼病(VL)治疗中的一个临床威胁。阐明耐药机制需要予以关注,以规避耐药问题。在其中一个耐药分离株中,我们之前鉴定出一个与锑耐药相关的基因(PG1),在本研究中其定位在寄生虫的表膜质膜上得到证实,从而表明膜修饰是该耐药分离株的一种耐药机制。